主动脉瘤颈长度与Ovation覆膜支架腔内修复术后远期结局的相关性
基于前瞻性国际多中心Ovation支架试验的238例患者,比较短瘤颈(<10 mm,41例)与标准瘤颈(≥10 mm)组5年结局。短瘤颈组5年全因死亡率升高,校正后风险约为标准瘤颈组的2倍,但两组动脉瘤相关死亡、Ia型内漏及再干预无显著差异。
要点
- 短瘤颈(<10 mm)组5年总体生存率为59.5%,标准瘤颈组为77.8%(P = .03)。
- 校正年龄等混杂因素后,短瘤颈与5年全因死亡风险约2倍相关(校正HR 2,95%CI 1.02-3.8,P = .04)。
- 两组5年免于动脉瘤相关死亡、Ia型内漏及再干预率均无显著差异。
核心结论
- Ovation覆膜支架在短瘤颈腹主动脉瘤中表现良好,5年Ia型内漏、再干预及动脉瘤相关死亡率无差异。
- 但短近端瘤颈与5年全因死亡风险约2倍独立相关。
- 这些发现证实了既往文献中不良瘤颈解剖与EVAR术后远期死亡的相关性。
研究设计与样本
- 研究纳入前瞻性国际多中心Ovation覆膜支架试验中接受EVAR的238例患者。
- 主要纳入标准为腹主动脉瘤直径≥5 cm、近端平行瘤颈长度≥7 mm、瘤颈成角≤60°、双侧髂动脉固定长度≥10 mm。
- 患者分为短瘤颈(<10 mm)组与标准瘤颈(≥10 mm)组。
主要发现
- 238例中41例(17.2%)近端瘤颈长度<10 mm,按其他支架说明书应视为超适应证。
- 中位随访58个月(四分位距36-60个月),患者以男性为主(81%),平均年龄73±8岁。
- 5年总体生存率标准瘤颈组为77.8%,短瘤颈组为59.5%(P = .03)。
- 5年免于动脉瘤相关死亡标准瘤颈组99.2% vs 短瘤颈组100%(P = .7),免于Ia型内漏两组均为96.3%(P = .8),免于再干预标准瘤颈组77.9% vs 短瘤颈组79.7%(P = .7)。
- 校正年龄及其他潜在混杂因素后,短近端瘤颈与5年全因死亡风险增加约2倍相关(校正HR 2,95%CI 1.02-3.8,P = .04)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular aneurysm repair (EVAR) performed outside manufacturers' instructions for use due to short aortic neck for the treatment of abdominal aortic aneurysm (AAA) is associated with unfavorable outcomes. Newer endografts now have an indication for shorter neck aneurysms that previous endografts do not, but this cohort has yet to be evaluated individually. The aim of this study is to evaluate 5-year outcomes after EVAR in patients with short aortic necks (<10 mm) using the Ovation stent graft. METHODS: The study comprised 238 patients who underwent EVAR as part of the prospective international multicenter Ovation stent graft trials. The main inclusion criteria were AAA diameter ≥ 5 cm, proximal parallel neck length ≥7 mm, neck angulation ≤60°, and bilateral iliac fixation length ≥10 mm. A clinical events committee adjudicated adverse events through 1 year, an independent imaging core laboratory analyzed imaging through 5 years, and a data safety and monitoring board provided study oversight. Patients were divided into short neck (<10 mm) and standard neck (≥10 mm) groups. End points included long-term survival, freedom from aneurysm-related mortality (ARM), freedom from type Ia endoleak, and freedom from reintervention. RESULTS: Patients were predominantly male (81%) with a mean age of 73 ± 8 years. Median follow-up time was 58 months (interquartile range, 36-60 months). Of 238 patients, 41 (17.2%) had a proximal neck length <10 mm and would be considered outside the instructions for use with other stent grafts. Baseline characteristics were relatively similar between the two groups. The 5-year overall survival estimates were 77.8% for the standard neck group compared with 59.5% for the short neck group (P = .03). There were no differences in the 5-year freedom from ARM (99.2% vs 100%; P = .7), freedom from type Ia endoleak (96.3% vs 96.3%; P = .8), and freedom from reintervention (77.9% vs 79.7%; P = .7) between the standard and short neck groups, respectively. After adjusting for age and other potential confounders, short proximal neck was associated with a two-fold increase in 5-year all-cause mortality (adjusted hazard ratio, 2; 95% confidence interval, 1.02-3.8; P = .04]. CONCLUSIONS: The Ovation endograft performed well in short AAA neck with no difference in 5-year type Ia endoleak, reintervention, and ARM rates. However, short proximal neck was independently associated with a two-fold increase in the risk of all-cause mortality at 5 years. These findings confirm the prior literature on the association of hostile neck anatomy with late mortality following EVAR.
引用
- Mathlouthi A, Khan MA, Al-Nouri O, et al. The correlation of aortic neck length to late outcomes following EVAR with the Ovation stent graft. J Vasc Surg. 2022. PMID: 34995716. doi:10.1016/j.jvs.2021.12.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。